Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Thyroid Cancer, Papillary × Vorinostat × 90 days × Clear all

Sponsor

Conditions

Myelodysplastic Syndromes 3 Leukemia, Myelomonocytic, Chronic 2 Leukemia, Myeloid, Acute 2 Anemia, Refractory, with Excess of Blasts 2 Uveal Melanoma 1 Recurrence 1 Prostatic Neoplasms 1 Primary Malignant Peripheral Nerve Sheath Tumors 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Oligodendroglioma 1 Neuroblastoma 1 Neoplasm Metastasis 1 Multiple Myeloma 1 Lymphoma, Non-Hodgkin 1 Lymphoma, Mantle-Cell 1 Lymphoma, Large B-Cell, Diffuse 1 Lymphoma, Follicular 1 Lymphoma, Extranodal NK-T-Cell 1 Lung Neoplasms 1 Leukemia, Myeloid, Chronic-Phase 1 Leukemia, Myeloid, Accelerated Phase 1 Leukemia, Megakaryoblastic, Acute 1 Leukemia, Erythroblastic, Acute 1 Hematologic Diseases 1 Graft vs Host Disease 1 Gliosarcoma 1 Glioma 1 Glioblastoma 1 GATA2 Deficiency 1 Carcinoma, Non-Small-Cell Lung 1

Interventions

entrectinib 2 Magnetic Resonance Spectroscopy 2 tremelimumab 1 trametinib 1 selpercatinib 1 gallium Ga 68 dotatate 1 durvalumab 1 dabrafenib 1 cobimetinib 1 X-Rays 1 Vemurafenib 1 Thyrotropin Alfa 1 Surveys and Questionnaires 1 Specimen Handling 1 Mitoxantrone 1 Iodine-131 1 High-Energy Shock Waves 1 Glycoprotein Hormones, alpha Subunit 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡